NVC-422 inactivates staphylococcus aureus toxins

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 924-929

  Jekle, Andreas ^a   Yoon, Jungjoo ^a   Zuck, Meghan ^a   Najafi, Ramin ^a   Wang, Lu ^b   Shiau, Timothy ^a   Francavilla, Charles ^a   Rani, Suriani Abdul ^b   Eitzinger, Christian ^b   Nagl, Markus ^b   Anderson, Mark ^a   Debabov, Dmitri ^a  

^a NovaBay Pharmaceuticals Inc   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; NVC 422; PROTEIN A; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CHEMICAL MODIFICATION; CONFORMATIONAL TRANSITION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BACTERIAL TOXINS; CELL PROLIFERATION; CYTOKINES; ENTEROTOXINS; EXFOLIATINS; METHIONINE; OXIDATION-REDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TAURINE;

EID: 84872872995     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01945-12     Document Type: Article

References (19)

1. Casadevall A, Pirofski LA. 1999. Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67: 3703-3713.
2. Gouaux E, Hobaugh M, Song L. 1997. alpha-Hemolysin, gammahemolysin, and leukocidin from Staphylococcus aureus: Distant in sequence but similar in structure. Protein Sci. 6:2631-2635.
3. Foster TJ. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3:948-958.
4. Llewelyn M, Cohen J. 2002. Superantigens: Microbial agents that corrupt immunity. Lancet Infect. Dis. 2:156-162.
5. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. 1999. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin. Microbiol. Rev. 12:224-242.
6. Goodyear CS, Silverman GJ. 2003. Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J. Exp. Med. 197:1125-1139.
7. Entenza JM, Foster TJ, Ni Eidhin D, Vaudaux P, Francioli P, Moreillon P. 2000. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect. Immun. 68:5443-5446.
8. Francois P, Schrenzel J, Stoerman-Chopard C, Favre H, Herrmann M, Foster TJ, Lew DP, Vaudaux P. 2000. Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J. Lab. Clin. Med. 135:32-42.
9. Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W. 2000. Bactericidal activity of micromolar N-chlorotaurine: Evidence for its antimicrobial function in the human defense system. Antimicrob. Agents Chemother. 44:2507-2513.
10. Gottardi, W, Nagl M. 2010. N-chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother. 65:399-409.
11. Iovino SM, Krantz KD, Blanco DM, Fernandez JA, Ocampo N, Najafi A, Memarzadeh B, Celeri C, Debabov D, Khosrovi B, Anderson M. 2011. NVC-422 topical gel for the treatment of impetigo. Int. J. Clin. Exp. Pathol. 4:587-595.
12. Wang L, Belisle B, Bassiri M, Xu P, Debabov D, Celeri C, Alvarez N, Robson MC, Payne WG, Najafi R, Khosrovi B. 2011. Chemical characterization and biological properties of NVC-422, a novel, stable Nchlorotaurine analog. Antimicrob. Agents Chemother. 55:2688-2692.
13. Nagl M, Hengster P, Semenitz E, Gottardi W. 1999. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J. Antimicrob. Chemother. 43:805-809.
14. Nagl M, Gruber A, Fuchs A, Lell CP, Lemberger EM, Borg-Von Zepelin M, Wurzner R. 2002. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob. Agents Chemother. 46:1996-1999.
15. Reeves EP, Nagl M, O'Keeffe J, Kelly J, Kavanagh K. 2006. Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin. J. Med. Microbiol. 55:913-918.
16. Gottardi W, Nagl M. 2005. Chlorine covers on living bacteria: The initial step in antimicrobial action of active chlorine compounds. J. Antimicrob. Chemother. 55:475-482.
17. Yoon J, Jekle A, Najafi R, Ruado F, Zuck M, Khosrovi B, Memarzadeh B, Debabov D, Wang L, Anderson M. 2011. Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis. Antiviral Res. 92:470-478.
18. Papageorgiou AC, Tranter HS, Acharya KR. 1998. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: Implications for superantigen recognition by MHC class II molecules and T-cell receptors. J. Mol. Biol. 277:61-79.
19. D'Lima L, Friedman L, Wang L, Xu P, Anderson M, Debabov D. 2012. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli. Antimicrob. Agents Chemother. 56: 2753-2755.